Parameter | Â | Number (%) |
---|---|---|
Total population | Â | 381 (100.0) |
Sex | Male | 238 (53.1) |
Female | 143 (46.9) | |
Age | < 60 years | 102 (26.8) |
≥ 60 years | 279 (73.2) | |
NSCLC | Adenocarcinoma | 228 (60.0) |
Squamous-cell carcinoma | 153 (40.0) | |
Stage | IA | 75 (19.8) |
IB | 47 (12.4) | |
IIA | 27 (7.1) | |
IIB | 27 (7.1) | |
IIIA | 70 (18.5) | |
IIIB | 39 (10.3) | |
IIIC | 2 (0.5) | |
IVA | 79 (20.8) | |
IVB | 13 (3.4) | |
Lymph node analysis | 1,799 (100%) | |
Lymph nodes | PET-positive | 450 (43.0) |
PET-negative | 1,349 (18.2) | |
Thoracic lymph node station | 1 | 98 (5.4) |
2 | 250 (13.9) | |
3 | 177 (9.8) | |
4 | 761 (42.3) | |
5 | 207 (11.5) | |
6 | 142 (7.9) | |
7 | 110 (6.1) | |
8 | 10 (0.6) | |
9 | 0 (0.0) | |
10 | 44 (2.4) |